également directeur de mon mémoire de DES, pour son encadrement dans mes travaux scientifiques mais aussi pour ses enseignements d'excellent chirurgien ,
co-directeur également de mon mémoire de DES que je remercie pour ses grandes qualités de statisticien ,
grands noms de la chirurgie gynécologique qui me font l'honneur de faire partie de mon jury ,
avec qui j'ai eu le privilège de travailler durant deux semestres au cours de mon internat ,
pour sa disponibilité et ses encouragements, sa volonté de me voir aller plus loin ,
collègue et néanmoins ami, pour ses enseignements en urologie mais aussi pour sa bonne humeur ,
Barei et Blanche pour m'avoir enseigné la chirurgie digestive ,
des modèles pour la suite ,
amie et collègue, à nos parcours conjoints depuis l'école de danse de notre petite ville de province ,
Cancer incidence and mortality in France over the 1980???2012 period: Solid tumors, Revue d'??pid??miologie et de Sant?? Publique, vol.62, issue.2, pp.95-108, 2014. ,
DOI : 10.1016/j.respe.2013.11.073
Cancer of the Ovary, New England Journal of Medicine, vol.351, issue.24, pp.2519-2548, 2004. ,
DOI : 10.1056/NEJMra041842
2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer, International Journal of Gynecological Cancer, vol.21, issue.4, pp.750-755, 2010. ,
DOI : 10.1097/IGC.0b013e31821b2568
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?, Gynecologic Oncology, vol.103, issue.2, pp.559-64, 2006. ,
DOI : 10.1016/j.ygyno.2006.03.051
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis, Gynecologic Oncology, vol.112, issue.1, pp.265-74, 2009. ,
DOI : 10.1016/j.ygyno.2008.08.033
Maximal cytoreductive effort in epithelial ovarian cancer surgery, Journal of Gynecologic Oncology, vol.21, issue.2, pp.75-80, 2010. ,
DOI : 10.3802/jgo.2010.21.2.75
Is the Decision for Colorectal Resection Justified by Histopathologic Findings: A Prospective Study of 100 Patients with Advanced Ovarian Cancer, Gynecologic Oncology, vol.83, issue.3, pp.481-485, 2001. ,
DOI : 10.1006/gyno.2001.6338
A RADICAL OPERATION FOR FIXED OVARIAN TUMOURS, BJOG: An International Journal of Obstetrics and Gynaecology, vol.207, issue.11, pp.1155-60, 1968. ,
DOI : 10.1111/j.1471-0528.1968.tb02901.x
Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer, Journal of the American College of Surgeons, vol.197, issue.4, pp.565-74, 2003. ,
DOI : 10.1016/S1072-7515(03)00478-2
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer, Gynecologic Oncology, vol.99, issue.3, pp.608-622, 2005. ,
DOI : 10.1016/j.ygyno.2005.07.112
The Western Australian Experience of the Use of en Bloc Resection of Ovarian Cancer with Concomitant Rectosigmoid Colectomy, Gynecologic Oncology, vol.84, issue.1, pp.53-60, 2002. ,
DOI : 10.1006/gyno.2001.6469
Safety and Efficacy of Low Anterior en Bloc Resection as Part of Cytoreductive Surgery for Patients with Ovarian Cancer, Gynecologic Oncology, vol.83, issue.1, pp.115-135, 2001. ,
DOI : 10.1006/gyno.2001.6353
Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer, Gynecologic Oncology, vol.103, issue.2, pp.667-72, 2006. ,
DOI : 10.1016/j.ygyno.2006.05.003
Modified Posterior Pelvic Exenteration for Ovarian Cancer, International Journal of Gynecological Cancer, vol.183, issue.5, pp.968-73, 2009. ,
DOI : 10.1111/IGC.0b013e3181a7f38b
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer1 1No competing interests declared., Journal of the American College of Surgeons, vol.193, issue.6, pp.626-658, 2001. ,
DOI : 10.1016/S1072-7515(01)01090-0
Une exent??ration pelvienne post??rieure avec??anastomose est-elle faisable et??justifi??e dans??le??traitement des??cancers de??l'ovaire ????un??stade ??volu?????, Annales de Chirurgie, vol.131, issue.8, pp.431-437, 2006. ,
DOI : 10.1016/j.anchir.2006.03.017
Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors, Gynecologic Oncology, vol.42, issue.2, pp.151-156, 1991. ,
DOI : 10.1016/0090-8258(91)90336-4
The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma, Obstetrics & Gynecology, vol.87, issue.4, pp.532-540, 1996. ,
DOI : 10.1016/0029-7844(95)00494-7
The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns, Gynecologic Oncology, vol.103, issue.3, pp.977-84, 2006. ,
DOI : 10.1016/j.ygyno.2006.06.004
Colon resection for ovarian cancer: Intraoperative decisions, Gynecologic Oncology, vol.111, issue.2, pp.56-65, 2008. ,
DOI : 10.1016/j.ygyno.2008.07.055
Comparison of Morbidity and Survival Between Primary and Interval Cytoreductive Surgery in Patients After Modified Posterior Pelvic Exenteration for Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.22, issue.8, pp.1349-54, 2012. ,
DOI : 10.1097/IGC.0b013e318265d358
Risk Factors for Anastomotic Leak After Colon Resection for Cancer, Annals of Surgery, vol.262, issue.2, 2014. ,
DOI : 10.1097/SLA.0000000000000973
Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes, Gynecologic Oncology, vol.126, issue.2, pp.220-223, 2012. ,
DOI : 10.1016/j.ygyno.2012.04.030
Predictors for Anastomotic Leak After Colorectal Resection, Annals of Surgery, vol.261, issue.6, 2013. ,
DOI : 10.1097/SLA.0000000000000458
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study, Journal of Clinical Oncology, vol.25, issue.33, pp.5165-71, 2007. ,
DOI : 10.1200/JCO.2007.11.5345
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer, Journal of Clinical Oncology, vol.25, issue.33, pp.5180-5186, 2007. ,
DOI : 10.1200/JCO.2007.12.0782
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2473-83, 2011. ,
DOI : 10.1056/NEJMoa1104390
A Phase 3 Trial of Bevacizumab in Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2484-96, 2011. ,
DOI : 10.1056/NEJMoa1103799
Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients, Annals of Surgical Oncology, vol.97, issue.2 ,
DOI : 10.1245/s10434-008-0279-2
Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: A case???control study, Gynecologic Oncology, vol.107, issue.3, pp.495-504, 2007. ,
DOI : 10.1016/j.ygyno.2007.08.003
Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.23, issue.7, pp.1326-1356, 2013. ,
DOI : 10.1097/IGC.0b013e31829dc923
Impact des curages r??trop??riton??aux sur la survie des patientes atteintes d???un cancer de l???ovaire ?? un stade avanc????: le protocole CARACO, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.3, pp.201-205, 2011. ,
DOI : 10.1016/j.jgyn.2011.02.009
Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.205-218, 2004. ,
DOI : 10.1097/01.sla.0000133083.54934.ae
Use of Clavien-Dindo Classification in Reporting and Grading Complications after Urological Surgical Procedures: Analysis of 2010 to 2012, The Journal of Urology, vol.190, issue.4, pp.1271-1275, 2013. ,
DOI : 10.1016/j.juro.2013.04.025
Anastomotic Leak Increases Distant Recurrence and Long-Term Mortality After Curative Resection for Colonic Cancer, Annals of Surgery, vol.259, issue.5, pp.930-938, 2014. ,
DOI : 10.1097/SLA.0b013e3182a6f2fc
Postoperative Peritoneal Infection Enhances Migration and Invasion Capacities of Tumor Cells In Vitro, Annals of Surgery, vol.260, issue.5, pp.939-982, 2014. ,
DOI : 10.1097/SLA.0000000000000958
Identifying Important Predictors for Anastomotic Leak After Colon and Rectal Resection, Annals of Surgery, vol.257, issue.1, pp.108-121, 2013. ,
DOI : 10.1097/SLA.0b013e318262a6cd
Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and considerations, Gynecologic Oncology, vol.114, issue.3, pp.427-457, 2009. ,
DOI : 10.1016/j.ygyno.2009.05.037
Multiple large bowel resections: Potential risk factor for anastomotic leak, Gynecologic Oncology, vol.130, issue.1, pp.213-221, 2013. ,
DOI : 10.1016/j.ygyno.2013.04.002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686884
Covering ileo-or colostomy in anterior resection for rectal carcinoma, Cochrane Database Syst Rev, issue.5, p.6878, 2010. ,
Wound complications after bevacizumab treatment in patients operated on for ovarian cancer, Anticancer Res. nov, vol.30, issue.11, pp.4743-4750, 2010. ,
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, American Journal of Obstetrics and Gynecology, vol.197, issue.6 ,
DOI : 10.1016/j.ajog.2007.10.495
Procedures Required to Accomplish Complete Cytoreduction of Ovarian Cancer: Is There a Correlation with ???Biological Aggressiveness??? and Survival?, Gynecologic Oncology, vol.82, issue.3, pp.435-476, 2001. ,
DOI : 10.1006/gyno.2001.6313